PNPLA3 and metabolic dysfunction-associated steatotic liver disease: The objectives of this study were to clarify the prevalence of CKD and the risk factors for CKD in patients with biopsy-proven NAFLD, and to measure changes in liver function to determine the risk factors for deterioration and development of incident CKD including PNPLA3 polymorphism in a follow-up cohort.